/PRNewswire/ Ibere Pharmaceuticals (the "Company") today announced that it will redeem all of its outstanding ordinary shares that were included in the.
Ibere Pharmaceuticals (NYSE:IBER – Get Rating) was the recipient of a significant increase in short interest during the month of March. As of March 15th, there was short interest totalling 4,300 shares, an increase of 186.7% from the February 28th total of 1,500 shares. Based on an average daily trading volume, of 17,200 shares, the […]
Ibere Pharmaceuticals (NYSE:IBER – Get Rating) was the target of a significant growth in short interest in February. As of February 28th, there was short interest totalling 1,500 shares, a growth of 400.0% from the February 13th total of 300 shares. Based on an average daily volume of 13,300 shares, the short-interest ratio is currently […]
/PRNewswire/ Ibere Pharmaceuticals (NYSE: IBER) (the "Company") today announced that it received a notice on May 25, 2021 from the New York Stock Exchange.
Weekly Summary Corporate dividends, name changes, new listings sfgate.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from sfgate.com Daily Mail and Mail on Sunday newspapers.